Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma

Journal of Pathology

Volumn 194, Issue 4, 2001, Pages 428-435

  Heideman, Danille A M ^a   Snijders, Peter J F ^a   Bloemena, Elisabeth ^a   Meijer, Chris J L M ^b   Johan A Offerhaus, G ^a   Meuwissen, Stefan G M ^a   Gerritsen, Winald R ^a   Craanen, Mikael E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

C met proto oncogene; Gastric cancer; Hepatocyte growth factor receptor; Immunohistochemistry; RT PCR; Tpr met oncogenic rearrangement

Indexed keywords

MESSENGER RNA; SCATTER FACTOR RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CAUCASIAN; CHROMOSOME 1; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOSARCOMA CELL; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA;

EID: 0034868238     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.934     Document Type: Article

References (37)

1. Gastric carcinoma: Imaging, staging, management
2. Molecular mechanism of stomach cancer
3. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
4. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET
5. The roles of hepatocyte growth factor/scatter factor and Met receptor in human cancers
6. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer
7. Frequent amplification of the c-met gene in scirrhous type stomach cancer
8. Activating mutations for the Met tyrosine kinase receptor in human cancer
9. Signalling requirements for oncogenic forms of the met tyrosine kinase receptor
10. The mutationally activated Met-receptor mediated motility and metastasis
11. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor
12. Autocrine hepatocyte growth factor/scatter factor-met signalling induces transformation and the invasive/metastatic phenotype in C127 cells
13. Creation of a hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties with increase tumorigenicity
14. Mechanisms of met oncogene activation
15. The activated human met gene encodes protein tyrosine kinase
16. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions
17. Lack of rearranged tpr-met mRNA expression in human gastric cancer cell lines and gastric mucosa and carcinoma
18. Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives
19. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma
20. WHO International Histological Classification of Tumors. The Histological Typing of Oesophageal and Gastric Tumors
21. Molecular cloning of a new transforming gene from a chemically transformed human cell line
22. Etablierung eines Panels von humanen heterotransplantierten Magenkarzinomen ein präklinisches Modell
23. Expression of HOXC4, HOXC5 and HOXC6 in human lymphoid cell lines, leukemias, and in benign and malignant lymphoid tissue
24. Expression of the Met/HGF receptor in normal and neoplastic human tissue
25. Aberrant expression of c-met mRNA in human gastric carcinomas
26. Participation of c-met in the progression of human gastric cancers: Anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells
27. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: Correlation to clinical features
28. Correlation between overexpression of c-met gene and the progression of gastric cancer
29. E-cadherin and c-met expression as a prognostic factor in gastric cancer
30. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas
31. Clinical significance of ras oncogene activation in human lung cancer
32. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products
33. Absence of ras gene mutation in early gastric carcinomas
34. Alternative splicing generates isoforms of the met receptor tyrosone kinase which undergo differential processing
35. The human hepatocyte growth factor receptor gene: Complete structural organization and promoter characterization
36. Intron-exon structure of the MET gene and cloning of an alternatively-spliced Met isoform reveals frequent exon-skipping of a single large internal exon